'At some point there's a face to the drug that you worked on and this Amgen Breakaway from cancer initiative is my chance to see a patient that survived.'
-Dr. Steve Elliot, Amgen Scientific Executive Director

Phwew! For a second I thought he was going to say the riders were the face of EPO, Amgen's blockbuster product.